Body Composition
This group collects compounds studied for effects on adipose and lean-tissue metabolism in cell culture and animal models. The literature spans incretin agonism in adipose and hepatic pathways, GHRH-analog research on visceral adipose tissue, lipolysis and β-adrenergic assays in adipocyte culture, and AMPK activation under metabolic stress. Endpoints are typically measured at the tissue or cellular level rather than as whole-organism outcomes.
Retatrutide
10–30mg · COA published
Triple agonist at GIP, GLP-1, and glucagon receptors — among the most actively studied compounds in current metabolic research.
- CAS
- 2381089-83-2
- MW
- 4731.32
- Purity
- Per published certificate
Tirzepatide
10–30mg · COA published
Dual GIP and GLP-1 receptor agonist — a 39-amino-acid synthetic peptide studied for combined incretin pathway activity.
- CAS
- 2023788-19-2
- MW
- 4813.45
- Purity
- Per published certificate
Tesamorelin
10–15mg · COA published
Stabilized 44-amino-acid GHRH analog — the longest GHRH sequence in common research use.
- CAS
- 218949-48-5
- MW
- 5135.86
- Purity
- Per published certificate
AOD-9604
5mg · COA published
C-terminal fragment of human growth hormone studied for lipolytic activity without the growth-promoting effects of the full hormone.
- CAS
- 221231-10-3
- MW
- 1815.08
- Purity
- Per published certificate
MOTS-c
10mg · COA published
16-amino-acid mitochondrial-derived peptide studied for AMPK activation and metabolic homeostasis.
- CAS
- 1627580-64-7
- MW
- 2174.61
- Purity
- Per published certificate
48
Certificates published
Published across 5 compoundsin this group, current and prior lots. Every certificate is issued by an independent laboratory and carries the issuing lab’s verification key, so each result can be checked with the laboratory directly.
Browse by research area
The same compounds, indexed by mechanism. Each area page lists everything in that category, not only the compounds studied for this goal.